Clinical Trial Update: A Study of the Efficacy and Safety of Intramuscular Ziprasidone Followed by Oral Ziprasidone for the Treatment of Psychosis [Phase 4]

View source ↗

Summary

Phase 4 trial updating the efficacy and safety of intramuscular ziprasidone followed by oral ziprasidone for psychosis in schizophrenia/mania.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Delusional Disorder
• Exacerbation of Psychosis
• Mania
• Schizophrenia

Drugs mentioned

• Ziprasidone (ziprasidone)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Schizophrenia, Mania | Phase 4 | Status: COMPLETED